title: [Laparoscopic myomectomy: preparation for procedure and operation technique].
abstract: Uterine leiomyomata are the commonest neoplasms of the female reproductive system in the procreative age. In these cases operation is still a treatment of choice. The procedure's range depends on: number, size and localisation of the myomas, patient's age and possession of children. Currently uterine leiomyomata are removed more frequent by endoscopic operations. We present the technique of laparoscopic myomectomy taking into consideration very important problem--patients' qualification this procedure. We pay attention to necessity of precise closing the wound in layers after removed myoma, which seems to prevent uterine rupture during pregnancy and labour. We also present some controversial aspects of using GnRH analogues. In summary we emphasise benefits of laparoscopic myomectomy particularly for women in the procreative age, who are planning pregnancy.
authors.affiliation: Kliniki Ginekologii i Połoznictwa Septycznego, Collegium Medicum UJ, Kraków.
authors.forename: Alfred
authors.initials: A
authors.lastname: Reroń
authors.forename: Magdalena
authors.initials: M
authors.lastname: Trojnar-Podleśny
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000295:instrumentation / Q000379:methods*; D010535:Laparoscopy / Q000379:methods; D007889:Leiomyoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D020360:Neoadjuvant Therapy; D012307:Risk Factors; D017329:Triptorelin Pamoate / Q000008:administration & dosage; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate